Chembio Diagnostics (CEMI +5.4%) trades up after saying it's commenced Clinical Laboratory...

|About: Chembio Diagnostics, Inc. (CEMI)|By:, SA News Editor

Chembio Diagnostics (CEMI +5.4%) trades up after saying it's commenced Clinical Laboratory Improvement Amendments waiver studies for its DPP HIV 1/2 Assay. The studies are required by the FDA to establish the quality standards for laboratory testing, which ensures the accuracy, reliability and timeliness of patient tests results regardless of where the tests are performed.